Prosight Management LP Buys $2.75M Stake in PROCEPT BioRobotics

The investment firm now owns about 0.14% of the medical robotics company.

Mar. 14, 2026 at 11:08am

Got story updates? Submit your updates here. ›

Prosight Management LP purchased a new stake of 76,991 shares in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) during the third quarter, valued at approximately $2.75 million. This represents about 0.14% ownership of the company by the investment firm.

Why it matters

PROCEPT BioRobotics is a medical device company that develops robotic systems for minimally invasive treatment of benign prostatic hyperplasia (BPH). The investment by Prosight Management suggests the firm sees growth potential in the company's technology and market position.

The details

According to a 13F filing with the SEC, Prosight Management LP purchased the new stake in PROCEPT BioRobotics during the third quarter of 2026. The 76,991 shares acquired make up approximately 0.14% of the company's outstanding stock.

  • Prosight Management LP purchased the stake in PROCEPT BioRobotics during the 3rd quarter of 2026.

The players

Prosight Management LP

An investment management firm that purchased a new stake in PROCEPT BioRobotics.

PROCEPT BioRobotics Corporation

A medical device company that develops robotic systems for minimally invasive treatment of benign prostatic hyperplasia (BPH).

Got photos? Submit your photos here. ›

The takeaway

Prosight Management's investment in PROCEPT BioRobotics suggests the firm sees strong growth potential in the company's robotic medical technology, which could signal broader investor interest and confidence in the future of the business.